Status:
COMPLETED
The Impact of GlowCaps Connect™ and Its Services on Hypertension Medication Adherence
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Medication Adherence
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators hypothesize that providing subjects on a once-a-day hypertension medication with GlowCaps ConnectTM will lead to an improvement in their medication adherence. The investigators propo...
Detailed Description
Participants will use the GlowCap system for 6 months. Group 1 * The GlowCap bottle provided for subjects in this group will passively track medication adherence over the course of the study * The p...
Eligibility Criteria
Inclusion
- Adult men and women age 18 and over
- Diagnosis of hypertension
- Take a once a day medication for hypertension
- Internet access via broadband (not dial-up)
- Home router
- A private email account
- Fluency in English (spoken and written)
- Have a Primary Care Physician
Exclusion
- People will be excluded if they are not able to adequately respond to researcher's questions or complete the surveys.
- People with significant cognitive deficits will be excluded.
- People will be excluded if they take more than three medications a day for hypertension.
- People will be excluded if they take more than five medications in one day.
- People will be excluded if they have total color blindness.
- People will be excluded if they are both blind and deaf.
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
139 Patients enrolled
Trial Details
Trial ID
NCT00985452
Start Date
August 1 2009
End Date
August 1 2010
Last Update
October 10 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.